`
` UNITED STATES PATENT AND TRADEMARK OFFICE
`________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`________________
`
`FITBIT, INC.,
`Petitioner,
`
`v.
`
`VALENCELL, INC.,
`Patent Owner
`________________
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`________________
`
`PETITIONER’S REPLY BRIEF ON REMAND
`
`
`
`
`
`
`
`
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`
`
`Valencell had ten pages to rebut Fitbit’s argument that remaining dependent
`
`claim 3-5 of the ’941 patent are invalid. Valencell spent the first eight of those
`
`pages addressing Apple’s Petition and procedural issues already resolved by the
`
`Board (Paper 57), and only the final two pages responding to Fitbit’s brief on
`
`remand. Valencell did not present any separate validity argument for claims 4-5.
`
`The Board is left with a one-sided record that claims 3-5 are obvious over the prior
`
`art. And because the IPR Petition included Fitbit’s prior art combinations,
`
`Valencell’s procedural arguments lack merit. The Board should, therefore, hold
`
`claims 3-5 of the ’941 patent invalid.
`
`I.
`
`Valencell Has No Response on the Merits
`
`Valencell presents only cursory arguments that claim 3 is valid, and fails to
`
`rebut that claims 3-5 are obvious in view of the petitioned grounds.
`
`First, Valencell characterizes the Federal Circuit’s statement that “[t]he
`
`Board’s narrowing construction may have no significance” as “dicta” (Resp. at 9),
`
`but does not dispute claim 3 is obvious in the Federal Circuit’s view. The identified
`
`prior art interfaces “enable[] a particular application” (e.g., Craw’s health-
`
`monitoring application and Lee’s mobile phone application) “to utilize data
`
`obtained from hardware,” and therefore render obvious the claimed “application-
`
`specific interface” under the Board’s and Federal Circuit’s construction. Br. at 6.
`
`Second, Valencell argues Craw’s interfaces are not “application-specific
`
`
`
`
`1
`
`
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`
`
`interfaces” because they “are designed to be interoperable” with multiple
`
`applications. Resp. at 9-10. As the Federal Circuit concluded, however, “[t]he
`
`Board’s narrowing construction may have no significance” because an
`
`“application-specific interface” directed to a particular application and an API
`
`“perform[] the same function.” Fitbit, Inc. v. Valencell, Inc., 964 F.3d 1112, 1117
`
`(Fed. Cir. 2020) (quoting Valencell’s expert admitting “application-specific
`
`interface” and API are “basically the same”). Significantly, Valencell does not
`
`dispute Craw’s teachings that its dictionary-based interfaces “[a]ct[] on the
`
`received information” in a way that “depend[s] on the goal of the application.”
`
`Craw ¶¶ 48, 256. Craw thus expressly teaches interfaces directed to a “particular
`
`application,” regardless of whether those interfaces are also “interoperable” with
`
`other applications.
`
`Third, Valencell challenges Fitbit’s obviousness combinations by arguing
`
`Fitbit failed to address “unexpected results,” but Valencell does not challenge the
`
`predictable nature of the proposed combination. See Resp. at 10; see also E.I.
`
`DuPont de Nemours & Co. v. Synvina C.V., 904 F.3d 996, 1011 (Fed. Cir. 2018)
`
`(discussing “shift[ing] the burden of production to the patent owner to
`
`demonstrate . . . unexpected results”). Valencell also contends “Fitbit’s only reason
`
`for combining Craw and Wolf with Luo is their similar technology and problems
`
`addressed.” Resp. at 10. The Board already held it was obvious to combine Luo
`
`
`
`
`2
`
`
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`
`
`with Craw in view of these similarities, and Valencell did not appeal that decision.
`
`FWD at 32, 42. There is no reason for the Board to second-guess that holding now,
`
`nor does Valencell rebut the motivation for combining Wolf with Luo and Craw in
`
`order to further “improve health state determinations.” Br. at 9.
`
`II. Valencell’s Procedural Arguments Cannot Save Claims 3-5
`
`The Petition challenged claim 3 based on Luo and Craw (Ground 1) or
`
`Mault, Al-Ali, and Lee (Ground 7) and claims 4-5 based on Luo, Craw, and Wolf
`
`(Ground 2). Fitbit’s opening brief on remand relied on those same Grounds. This
`
`should end the inquiry. None of Valencell’s arguments to the contrary have merit.
`
`Valencell conflates “grounds” with specific “arguments.” See Paper 57 at
`
`10-11 (allowing Fitbit to address “the patentability of claims 3-5 . . . on the
`
`grounds presented in” the Petition). Fitbit should not be limited to the specific
`
`words in the Petition, especially since the Board adopted a new construction in its
`
`institution decision, and in view of the Federal Circuit’s instructions on remand.
`
`See Ericsson Inc. v, Intellectual Ventures I LLC, 901 F.3d 1374, 1380 (Fed. Cir.
`
`2018) (decision after SAS finding Board erred in not considering petitioner’s reply
`
`arguments regarding prior art disclosure of “encoding” under the Board’s
`
`construction). In any event, Fitbit presented the same arguments at least in its
`
`additional briefing (Paper 40), which in turn cites to the request for rehearing
`
`(Paper 13), and which Valencell did not move to exclude.
`
`
`
`
`3
`
`
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`
`
`Nor is Fitbit relying on new “evidence” in its opening brief. Fitbit relies on
`
`the same prior art combinations, and even the same paragraphs of Craw, as in the
`
`Petition. See Fitbit’s Response to Identification. Valencell is also wrong to equate
`
`“uncited portions of Craw” to “new evidence.” Resp. at 7. “Evidence consists of
`
`affidavits, transcripts of depositions, documents, and things” (37 C.F.R. § 42.63),
`
`and not cites thereto. Nor is the Board’s prior rejection in IPR2017-00321 of the
`
`same limitations over Craw new “evidence.” Claim 3 is unpatentable over Craw
`
`regardless of whether the Board consults those findings.
`
`For claim 4-5, Valencell argues Fitbit should not be allowed to make any
`
`invalidity argument based on the correct dependency. But the Board permitted
`
`Fitbit to address “the patentability of claims 4 and 5, assuming their dependency
`
`from claim 3” (Paper 57 at 10), and the Federal Circuit instructed the Board to
`
`“determine patentability of corrected claims 4 and 5 on the asserted grounds of
`
`obviousness.” Fitbit, Inc., 964 F.3d at 1120. Accordingly, Valencell had every
`
`opportunity to rebut Fitbit’s invalidity arguments for claims 3-5, but time and again
`
`failed to do so. The Board should dispose of the last remnants of the ’941 patent.
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`
`
` By: /Jim Glass/
`James M. Glass (Reg. No. 46,729)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Email: jimglass@quinnemanuel.com
`Phone: 212-849-7142
`Fax: 212-849-7100
`
`Counsel for Petitioner Fitbit, Inc.
`
`
`Date: November 9, 2020
`
`
`
`
`
`
`
`5
`
`
`
`
`
`
`
`
`IPR2017-00319
`U.S. Patent No. 8,923,941
`
`
`CERTIFICATE OF SERVICE (37 C.F.R. §§ 42.6(E), 42.105(A))
`
`
`
`The undersigned hereby certifies that the foregoing document was served in
`
`its entirety on November 9, 2020 upon the following parties via Electronic Mail.
`
`Justin B. Kimble
`Jeffrey R. Bragalone
`Daniel F. Olejko
`T. William Kennedy
`Jonathan H. Rastegar
`Marcus Benavides
`R. Scott Rhoades
`Sanford E. Warren, Jr
`
`BRAGALONE CONROY PC
`2200 Ross Ave.
`Suite 4500 – West
`Dallas, TX 75201
`JKimble-IPR@bcpc-law.com
`
`jbragalone@bcpc-law.com
`dolejko@bcpc-law.com
`bkennedy@bcpc-law.com
`jrastegar@bcpc-law.com
`mbenavides@bcpc-law.com
`srhoades@wriplaw.com
`swarren@wriplaw.com
`
`Date: November 9, 2020
`
`
`
`
`
`
`
`
`
`
` By: /Jim Glass/
`James M. Glass (Reg. No. 46,729)
`QUINN EMANUEL URQUHART &
`SULLIVAN LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`Email: jimglass@quinnemanuel.com
`Phone: 212-849-7142
`Fax: 212-849-7100
`
`Counsel for Petitioner Fitbit, Inc.
`
`6
`
`